Is DXCM a good stock to buy? We came across a bullish thesis on DexCom, Inc. on Part-Time Compounder’s Substack by Francesco ...

The Middle East and Africa Continuous Glucose Monitoring (CGM) market is set for growth, driven by increasing diabetes rates, technological advancements, and healthcare awareness. Projected to rise ...

The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a phased roll out ...

Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...

Wearable technology makes it easier to track health metrics. Ask Dr. Denise Dennis-Coke about health-tracking devices, and she’ll show you the ones she’s wearing. “I have on my Dexcom Stelo, my Oura ...

Senseonics has launched its Eversense 365 continuous glucose monitoring system in Europe, offering a sensor lifespan of one year. The rollout starts in Sweden, with Germany, Spain, and Italy to follow ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...

A landmark trial has confirmed real-time continuous glucose monitoring (CGM) improves blood sugar control in type 2 diabetes, while new wearable sensors promise broader, continuous biomarker tracking.

Senseonics (Nasdaq:SENS) announced today that it initiated the first European launch of its Eversense 365 continuous glucose ...